NYU Langone Health - Inflammatory Bowel Disease Center (IBD) — New York, New York

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Crohn's Disease.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health - Inflammatory Bowel Disease Center (IBD)?

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health - Inflammatory Bowel Disease Center (IBD) conducted?

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) has 1 clinical trials on record, with 1 currently active. Their work covers Crohn's Disease.

Is NYU Langone Health - Inflammatory Bowel Disease Center (IBD) accredited by Crixeo Health?

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health - Inflammatory Bowel Disease Center (IBD)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.